Tempest Therapeutics

TPST • NASDAQ • Stock Fundamentals

Tempest Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Matthew Angel, with a market cap of $26.2M.

Market Cap$26.2M

Employees17.0

CEOMatthew Angel

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 15, 2026 · 13 days agoQ1 2026

Next EarningsAug 10, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Tempest Therapeutics

Tempest Therapeutics (TPST) has a market capitalization of $26.2M and trades on NASDAQ.

Tempest Therapeutics has approximately 17 employees.